A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography

A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR)

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00447889

Enrollment

Unknown

Registered

2007-03-15

Start date

2006-03-31

Completion date

2007-11-30

Last updated

2008-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Occlusive Disease

Brief summary

This is a clinical study of gadoteric acid in non-coronary MR angiography.

Interventions

DRUGgadoteric acid

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male or female, at least the age of legal maturity * Strongly suspected of having non-coronary arterial disease, detected clinically * Scheduled to undergo x-ray angiography examination * Female patients must be using effective contraception or be surgically sterilized or post-menopausal. * Females of childbearing potential must have a documented negative urine pregnancy test.

Exclusion criteria

* Contraindication to magnetic resonance imaging (MRI) * Any metallic medical device in the vascular territory for which the patient is to undergo imaging examinations * Congenital morphologic vascular abnormalities * Known allergy to gadolinium chelates * Pregnant, breast feeding, or planning to become pregnant during the trial * Received a gadolinium complex within 2 days or iron oxide nanoparticles within 7 days before the gadoteric acid-enhanced magnetic resonance angiography (MRA) examination.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026